US Broker Ratings

ImmunityBio, Inc. (IBRX) Stock Analysis: Biotechnology Innovator with a 358% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with a remarkable potential upside of 358.15%, according to recent analyst ratings. As a dynamic player in the biotechnology sector,..

Alvotech (ALVO) Stock Analysis: Unpacking the 348% Potential Upside

Alvotech (NASDAQ: ALVO), a burgeoning player in the healthcare sector, is making waves with its focus on developing and manufacturing biosimilar medicines. Based in Luxembourg, Alvotech is positioned within the..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Potential 48% Upside in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a rising star within the biotechnology industry, recently captured investor attention with its promising growth trajectory and substantial upside potential. With a market capitalization of..

Privia Health Group, Inc. (PRVA) Stock Analysis: 30% Potential Upside Ignites Investor Interest

Privia Health Group, Inc. (NASDAQ: PRVA) is capturing the attention of investors with its impressive 30.15% potential upside, presenting a compelling opportunity in the healthcare sector. As a national leader..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a Promising 9% Upside in the Fertility Solutions Space

Progyny, Inc. (NASDAQ: PGNY), a specialized healthcare plans provider, is making waves in the U.S. market with its innovative approach to fertility and family-building benefits. With a market capitalization of..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 9.2% Potential Upside with Strong Buy Ratings

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a key player in the healthcare sector, is making waves with its diverse portfolio of generic and specialty pharmaceuticals. With a market capitalization of $4.03..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Investors Eye a 27% Upside Potential in Biotech Innovation

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has captured the attention of investors seeking opportunities in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $4.19 billion, this..

Merus N.V. (MRUS) Stock Analysis: A Close Look at Its Flat Performance and Growth Prospects

Merus N.V. (NASDAQ: MRUS), a biotechnology firm based in the Netherlands, is navigating the complex waters of the healthcare sector with a focus on antibody therapeutics, particularly for oncology indications...

Arcellx, Inc. (ACLX) Stock Analysis: Unveiling a 72% Potential Upside in Biotech Innovation

Arcellx, Inc. (NASDAQ: ACLX) is capturing the attention of investors with its promising advancements in biotechnology. Specializing in the development of cutting-edge immunotherapies for cancer and other incurable diseases, Arcellx..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 26.36% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare space, particularly in the medical devices industry, is capturing the attention of investors with its robust array of diagnostic solutions...

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Promising Biotech with an 18.84% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention in the biotechnology sector, offering promising growth potential with an impressive 18.84% upside. As a commercial-stage pharmaceutical company, Harmony focuses..

Clover Health Investments (CLOV): Assessing Its 24% Potential Upside and Revenue Growth Prospects

Clover Health Investments, Corp. (NASDAQ: CLOV) continues to intrigue investors with its innovative approach to healthcare plans, particularly in the Medicare Advantage space. Based in Wilmington, Delaware, the company is..

CG Oncology, Inc. (CGON): Investor Outlook Reveals 76% Potential Upside in Biotech Stock

CG Oncology, Inc. (CGON) is emerging as an intriguing prospect within the biotech sector, with its focus on innovative bladder-sparing therapeutics for bladder cancer patients. As a late-stage clinical biopharmaceutical..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Look at the 72.57% Potential Upside

Ascentage Pharma Group International (AAPG), a notable player in the biotechnology sector, is capturing investor attention with a significant potential upside of 72.57%, according to analyst ratings. This clinical-stage biotechnology..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth in the Healthcare Sector

Warby Parker Inc. (NYSE: WRBY), a key player in the Healthcare sector’s Medical Instruments & Supplies industry, presents an intriguing proposition for investors looking at the intersection of healthcare and..

MoonLake Immunotherapeutics (MLTX) Investor Outlook: Exploring the 8.28% Upside Potential in Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating inflammatory diseases. Based in Zug, Switzerland, MoonLake is focused..

Veracyte, Inc. (VCYT) Stock Analysis: Healthcare Innovator’s 10.23% Upside Potential Beckons Investors

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. Headquartered in South San Francisco, California, the company is renowned..

Sotera Health Company (SHC) Stock Analysis: Evaluating a 9.54% Upside Potential in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC), a leading player in the healthcare industry, is drawing significant attention from investors due to its promising growth metrics and favorable analyst ratings. With a..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Analyzing a Potential 163.81% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, is capturing the attention of investors with the promise of substantial upside potential. As it stands, the stock boasts a significant..

Zai Lab Limited (ZLAB) Investor Outlook: Analyzing a Potential 177.64% Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to innovative healthcare solutions. Headquartered in Pudong, China, Zai Lab’s..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds